Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 509760, "name": "Divi's Lab.", "stock_name": "Divi's Lab.", "full_name": "Divis Laboratories Ltd", "name_url": "stocks-analysis/divi-s-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "8,248.50", "chg": -43.05, "chgp": "-0.52%", "dir": -1, "prev_price": "8,291.55", "mcapval": "221,150.00 Cr", "mcap": "Large Cap", "scripcode": 532488, "symbol": "DIVISLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE361B01024", "curr_date": "Aug 07, 03:30 PM", "curr_time": "14:53 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "3.25 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Divis Laboratories Gains 2.38%: 5 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-238-5-key-factors-driving-the-weeks-momentum-4143632", "imagepath": "", "date": "2026-08-08 17:09:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> New 52-week and all-time high at Rs 8,417.25</p>\n <p><strong>3 Aug:</strong> Surge in call and put option activity ahead of 25 Aug expiry</p>\n <p><strong>4 Aug:</strong> High-value trading with strong institutional participation</p>\n <p><strong>7 Aug:</strong> Week closes at Rs 8,248.50, up 2.38% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8,056.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Divis Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-buy-4139610", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_mojoScore_4139610.png", "date": "2026-08-06 10:11:23", "description": "Divis Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 July 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with the latest comprehensive analysis." }, { "title": "Divis Laboratories Ltd Sees High-Value Trading Amid Institutional Interest", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-sees-high-value-trading-amid-institutional-interest-4135959", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_most_active_equities_by_value_4135959.png", "date": "2026-08-04 12:00:07", "description": "Divis Laboratories Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 August 2026. Despite a modest intraday decline, the stock’s robust trading volumes and recent upgrade in its Mojo Grade to ‘Buy’ underscore growing institutional confidence and sustained investor interest in this large-cap pharmaceutical leader." }, { "title": "Rs 8,000 Puts Draw 1,896 Contracts on Divis Laboratories Ltd as Stock Holds Near 52-Week High", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-bearish-sentiment-4135330", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_most_active_stocks_puts_4135330.png", "date": "2026-08-04 10:00:12", "description": "Rs 8,000 put options on Divis Laboratories Ltd attracted 1,896 contracts on 4 August 2026, signalling notable activity just below the current stock price of Rs 8,286. This surge in put trading comes as the stock trades within 3.23% of its 52-week high, raising questions about whether the options market is signalling protection, bearish positioning, or a bullish stance through put writing." }, { "title": "Divis Laboratories Ltd Rallies 3.91% and Hits New 52-Week High of Rs 8417.25", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-strong-391-surge-on-3-aug-2026-4133440", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_priceRelatedfactors_4133440.png", "date": "2026-08-03 10:01:41", "description": "The Sensex slipped 0.75% on 3 Aug 2026, yet Divis Laboratories Ltd surged 3.91%, touching a fresh 52-week and all-time high of Rs 8417.25. That 3.16-percentage-point outperformance over the benchmark index signals a distinctly stock-specific strength rather than a market-wide rally." }, { "title": "At-the-Money Calls on Divis Laboratories Ltd Draw 10,939 Contracts — A Signal of Immediate Directional Conviction", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-surge-in-call-option-activity-amid-bullish-market-sentiment-4133343", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_most_active_stocks_calls_4133343.png", "date": "2026-08-03 10:00:09", "description": "On 3 Aug 2026, Divis Laboratories Ltd witnessed significant call option activity, with 10,939 contracts traded at the Rs 8,400 strike price, precisely matching the stock’s closing price of Rs 8,400. This synchrony between the options strike and the underlying price highlights a strong directional bet on near-term price movement, supported by a 3.91% gain in the cash market on the same day." }, { "title": "Divis Laboratories Ltd Sees Robust Trading Activity Amid Strong Institutional Interest", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-sees-robust-trading-activity-amid-strong-institutional-interest-4133298", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_most_active_equities_by_value_4133298.png", "date": "2026-08-03 10:00:09", "description": "Divis Laboratories Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value, reflecting heightened investor interest and institutional participation. The stock’s recent upgrade from a Hold to a Buy grade by MarketsMOJO, coupled with strong volume and value turnover, underscores its growing appeal amid a volatile market backdrop." }, { "title": "Rs 8,000 Puts — 4.6% Below Current Price — Draw 4,128 Contracts on Divis Laboratories Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-mixed-price-action-4133340", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_most_active_stocks_puts_4133340.png", "date": "2026-08-03 10:00:09", "description": "Rs 8,000 put options on Divis Laboratories Ltd attracted 4,128 contracts on 3 Aug 2026, signalling notable activity at a strike price 4.6% below the current market price of Rs 8,380. This surge in put volume comes amid a five-day rally that has lifted the stock by 8.66%, raising questions about whether this is a protective hedge or a bearish wager." }, { "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-strong-market-momentum-4133296", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_oi_spurts_by_underlying_4133296.png", "date": "2026-08-03 10:00:06", "description": "Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes alongside the stock hitting a fresh 52-week high and sustained gains over the past week, underscoring a bullish sentiment despite some intraday volatility." } ], "total": 716, "sid": "509760", "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "06-Aug-2026", "details": "Submission of transcript of Earnings Conference Call held on August 01 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "03-Aug-2026", "details": "Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30 2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 01 2026.", "datetime": "01-Aug-2026", "details": "Outcome of Board meeting held on August 01 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07", "dt": "2007-08-03", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15", "dt": "2015-09-23", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: New 52-week and all-time high at Rs 8,417.25

3 Aug: Surge in call and put option activity ahead of 25 Aug expiry

4 Aug: High-value trading with strong institutional participation

7 Aug: Week closes at Rs 8,248.50, up 2.38% for the week

Read full news article

Divis Laboratories Ltd is Rated Buy

2026-08-06 10:11:23

Divis Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 July 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with the latest comprehensive analysis.

Read full news article

Divis Laboratories Ltd Sees High-Value Trading Amid Institutional Interest

2026-08-04 12:00:07

Divis Laboratories Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 August 2026. Despite a modest intraday decline, the stock’s robust trading volumes and recent upgrade in its Mojo Grade to ‘Buy’ underscore growing institutional confidence and sustained investor interest in this large-cap pharmaceutical leader.

Read full news article

Rs 8,000 Puts Draw 1,896 Contracts on Divis Laboratories Ltd as Stock Holds Near 52-Week High

2026-08-04 10:00:12

Rs 8,000 put options on Divis Laboratories Ltd attracted 1,896 contracts on 4 August 2026, signalling notable activity just below the current stock price of Rs 8,286. This surge in put trading comes as the stock trades within 3.23% of its 52-week high, raising questions about whether the options market is signalling protection, bearish positioning, or a bullish stance through put writing.

Read full news article

Divis Laboratories Ltd Rallies 3.91% and Hits New 52-Week High of Rs 8417.25

2026-08-03 10:01:41

The Sensex slipped 0.75% on 3 Aug 2026, yet Divis Laboratories Ltd surged 3.91%, touching a fresh 52-week and all-time high of Rs 8417.25. That 3.16-percentage-point outperformance over the benchmark index signals a distinctly stock-specific strength rather than a market-wide rally.

Read full news article

At-the-Money Calls on Divis Laboratories Ltd Draw 10,939 Contracts — A Signal of Immediate Directional Conviction

2026-08-03 10:00:09

On 3 Aug 2026, Divis Laboratories Ltd witnessed significant call option activity, with 10,939 contracts traded at the Rs 8,400 strike price, precisely matching the stock’s closing price of Rs 8,400. This synchrony between the options strike and the underlying price highlights a strong directional bet on near-term price movement, supported by a 3.91% gain in the cash market on the same day.

Read full news article

Divis Laboratories Ltd Sees Robust Trading Activity Amid Strong Institutional Interest

2026-08-03 10:00:09

Divis Laboratories Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value, reflecting heightened investor interest and institutional participation. The stock’s recent upgrade from a Hold to a Buy grade by MarketsMOJO, coupled with strong volume and value turnover, underscores its growing appeal amid a volatile market backdrop.

Read full news article

Rs 8,000 Puts — 4.6% Below Current Price — Draw 4,128 Contracts on Divis Laboratories Ltd

2026-08-03 10:00:09

Rs 8,000 put options on Divis Laboratories Ltd attracted 4,128 contracts on 3 Aug 2026, signalling notable activity at a strike price 4.6% below the current market price of Rs 8,380. This surge in put volume comes amid a five-day rally that has lifted the stock by 8.66%, raising questions about whether this is a protective hedge or a bearish wager.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-08-03 10:00:06

Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes alongside the stock hitting a fresh 52-week high and sustained gains over the past week, underscoring a bullish sentiment despite some intraday volatility.

Read full news article